Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,632,595
-
Share change
-
-2,341,698
-
Total reported value
-
$164,248,305
-
Put/Call ratio
-
160%
-
Price per share
-
$6.95
-
Number of holders
-
94
-
Value change
-
-$11,828,389
-
Number of buys
-
63
-
Number of sells
-
21
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q1 2019
As of 31 Mar 2019,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,632,595 shares.
The largest 10 holders included
BlackRock Inc., Knoll Capital Management, LP, VANGUARD GROUP INC, FMR LLC, D. E. Shaw & Co., Inc., MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and GENERAL AMERICAN INVESTORS CO INC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.